Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Updated June 2026 · ClinicalTrials.gov

Children's Hospital Medical Center, Cincinnati

Reviewed by TrialFinderData Editorial Team · Updated

25 clinical trials · 25 recruiting · OTHER

Children's Hospital Medical Center, Cincinnati has 25 clinical trials registered on ClinicalTrials.gov, with 25 actively recruiting participants. The trials listed below cover 20 conditions across the phases listed in the sidebar. Always discuss any specific trial with your physician before contacting a study site.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About Children's Hospital Medical Center, Cincinnati\'s Trial Portfolio

Children's Hospital Medical Center, Cincinnati is a non-industry sponsor (academic medical center, hospital, foundation, or research network). Non-industry sponsors often investigate novel approaches, rare conditions, and behavioral or surgical interventions that commercial sponsors may not prioritize.

25 of Children's Hospital Medical Center, Cincinnati's 25 registered trials are currently recruiting — roughly 100% of the portfolio. A high recruiting share usually points to an active research pipeline with multiple programs at the enrollment stage.

Children's Hospital Medical Center, Cincinnati's research footprint spans Cystic Fibrosis (4 trials), Sickle Cell Anemia (3), and Sickle Cell Disease (3) as the top three conditions. The full condition list, sorted by trial count, is in the sidebar.

Not Applicable is the largest single phase in Children's Hospital Medical Center, Cincinnati's portfolio at 44% of registered trials. The full phase breakdown appears in the sidebar.

Trials by Children's Hospital Medical Center, Cincinnati

RECRUITINGNCT07321353

Survivors Journey+

The main goal of this pilot randomized controlled trial is to learn if an online program called "Survivors Journey" (SJ+) can help teens and young adults, ages 15-25, who are...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 722 locations
Pediatric Brain Tumor
RECRUITINGNCT04715685

Mind Body Balance for Pediatric Migraine

This study uses a factorial research design to evaluate a nurse delivered mind body intervention using different doses of 3 treatment components to determine the optimized...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2602 locations
HeadacheHeadache DisordersHeadache, Migraine+5
RECRUITINGNCT05622461

Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery

This study has two main goals: 1) to refine and enhance the R2R-TBI intervention; and 2) to examine the efficacy of the R2R-TBI intervention in a randomized control trial. To...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2001 location
Traumatic Brain InjuryHead InjuryHead Injuries, Closed+3
RECRUITINGNCT06960980

Improving ADHD Teen Driving - Virtual Reality

Teens with Attention-Deficit/Hyperactivity Disorder (ADHD) have high rates of negative driving outcomes, including motor vehicle crashes, which may be caused by visual inattention...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2041 location
Attention Deficit Hyperactivity Disorder (ADHD)
RECRUITINGPhase 4NCT04219280

Evaluating Treatment of ADHD in Children with Down Syndrome

Children with Down syndrome (DS) have a 3-5 time greater prevalence of Attention Deficit Hyperactivity Disorder (ADHD) than typically developing (TD) children. Despite this higher...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1004 locations
Down SyndromeADHD
RECRUITINGNCT06552286

STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade

The current study seeks to compare outcomes of a telehealth intervention targeting daily living skills (Surviving and Thriving in the Real World - Telehealth, or STRW-T)...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1922 locations
Autism Spectrum Disorder
RECRUITINGNCT06896942

Autism Doula Program Evaluation

Background: Findings from a group level assessment with caregivers of Black children with autism revealed barriers to equitable care and services (e.g., a lack of cultural...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 521 location
Health EquityAutism Spectrum Disorder
RECRUITINGNCT07602595

The BRIDGE Pain Study

The purpose of the study is to discover at least two distinct Musculoskeletal pain subtypes. These types are caused by different brain-and-immune system signals that affect how...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 6001 location
Juvenile Idiopathic Arthritis (JIA)FibromyalgiaLupus+4
RECRUITINGPhase 2NCT05538208

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 10519 locations
Lupus Nephritis
RECRUITINGPhase 1 / Phase 2NCT03847467

Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF...

Randomized, placebo-controlled dose-ranging study of 2'-FL in IBD, Crohn's Disease (CD) and ulcerative colitis (UC). The overarching hypothesis is that 2'-FL supplementation in...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1163 locations
Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
RECRUITINGNCT07195123

Evaluation of the SMART IBD App in Pediatric IBD

The objective of this trial is to test whether a smartphone app, SMART-IBD, is effective in improving medication adherence and self-management skills in adolescents with IBD. The...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 701 location
Inflammatory Bowel Disease (IBD)IBD (Inflammatory Bowel Disease)IBD - Inflammatory Bowel Disease+4
RECRUITINGNCT06159127

SMART@Home Feasibility Trial

The proposed research addresses the limitations or lack of a digital platform to provide remote care of medically complex patients. Previous attempts have had poor clinical...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 251 location
AsthmaAsthma in Children
RECRUITINGPhase 4NCT05517655

BEGIN Novel ImagiNG Biomarkers

To determine the treatment effect of triple-combination therapy in 6-8 year olds after presumed FDA approval, using rapid structural and functional pulmonary and abdominal MRI...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 443 locations
Cystic Fibrosis
RECRUITINGNCT04793867

Regional Phenotyping of CF and Non-CF Bronchiectasis

The Investigators propose to study pediatric subjects who are diagnosed with cystic fibrosis (CF) and patients with non-CF bronchiectasis, with the goal of developing markers of...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1001 location
Cystic FibrosisNon-CF Bronchiectasis
RECRUITINGNCT04580368

Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials

The purpose of this study is to validate and utilize a personalized medicine approach to identify potential treatments with current FDA approved CFTR modifiers for non-approved CF...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 501 location
Cystic Fibrosis
RECRUITINGEarly Phase 1NCT06339593

Regional Monitoring of CF Lung Disease

The main reason for this research study is to learn more about some new tests that are being developing for patients with Cystic Fibrosis (CF) to measure changes in the lungs. In...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 601 location
Cystic Fibrosis
RECRUITINGNCT06609694

Comparison of a Demand Oxygen Delivery

Conducting a randomized control trial of oxygen in children with Down syndrome to treat moderate to severe obstructive sleep apnea. The aim of the study is to conduct a...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 101 location
Obstructive Apnea
RECRUITINGNCT07077213

18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) in Tuberculosis Patients

The investigators will assess the hypothesis is that 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) Positron emission tomography (PET) could be used as a noninvasive...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 301 location
Tuberculosis, Pulmonary
RECRUITINGPhase 2NCT04925375

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 386 locations
Interstitial Lung DiseaseCommon Variable Immunodeficiency
RECRUITINGNCT07116772

Serial Assessment of Fertility Experiences

The SAFE study is a long-term research project that watches people with sickle cell anemia (SCA) over time. The main goal is to see how a medicine called hydroxyurea affects their...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2503 locations
Sickle Cell Anemia
RECRUITINGNCT07356050

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children...

The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 1303 locations
Sickle Cell DiseaseMeasles VaccinationSickle Cell Anemia
RECRUITINGNCT06301893

Uganda Sickle Surveillance Study (US-3)

It is estimated that over 250,000 babies are born with sickle cell disease (SCD) annually in sub-Saharan Africa, and only 10% - 50% of them survive beyond five years of age. Data...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 10000004 locations
Sickle Cell Disease
RECRUITINGPhase 4NCT07177300

Effectiveness of Nontraditional Hydroxyurea Algorithms: Novel and Clinical Evaluations (ENHANCE)

The main reason for this research study is to learn more about hydroxyurea and the treatment of sickle cell anemia (SCA). Hydroxyurea is a medication that has been studied for...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 501 location
Sickle Cell Anemia (HbSS)Sickle-β0-thalassemia (HbSβ0)
RECRUITINGNCT06290401

A Socio-ecological Approach for Improving Self-management in Adolescents With SCD

The goal of this clinical trial is to evaluate the impact of SCThrive (a behavioral self-management intervention) on patient activation, self-management behaviors, daily...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 3104 locations
Anemia, Sickle Cell
RECRUITINGNCT04093986

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

The purpose of this research study is to document and understand the effects of hydroxyurea exposure for women with SCD and their babies, during both gestation and lactation.

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 2001 location
Sickle Cell DiseaseSickle Cell Anemia

How to Approach a Trial Listing

Each trial card above links to a dedicated page with the official ClinicalTrials.gov data plus a plain-English translation of the eligibility criteria. We translate technical terminology (ECOG performance status, hepatic function values, exclusionary lab thresholds) into language that a patient or caregiver can understand, but the original clinical text and the live ClinicalTrials.gov record always govern any actual eligibility decision.

Before contacting a trial site, write down questions for your treating physician using the framework on our 25 Questions guide. Discuss whether the trial fits your treatment plan, what the time commitment looks like, and whether your insurance will cover the standard-of-care portions. Trials are not a substitute for a treatment plan — they are an addition that needs medical guidance to evaluate.

Authoritative Resources

Verify any trial registration directly on ClinicalTrials.gov. For background on the FDA approval pathway that Phase 3 trials feed into, see the FDA drug approval process. For cancer-specific trial guidance, the National Cancer Institute publishes patient-oriented overviews. For global trial registrations beyond the U.S., the WHO ICTRP aggregates registries from around the world.

Frequently Asked Questions

How many clinical trials does Children's Hospital Medical Center, Cincinnati have on ClinicalTrials.gov?

Children's Hospital Medical Center, Cincinnati has 25 clinical trials registered on the federal ClinicalTrials.gov registry, of which 25 are actively recruiting participants right now. These counts come directly from the ClinicalTrials.gov API and are updated as the registry changes.

What conditions does Children's Hospital Medical Center, Cincinnati study?

Children's Hospital Medical Center, Cincinnati's registered trials cover 20 conditions on ClinicalTrials.gov, led by Cystic Fibrosis (4 trials), Sickle Cell Anemia (3 trials), Sickle Cell Disease (3 trials), Autism Spectrum Disorder (2 trials), Ibd (Inflammatory Bowel Disease) (2 trials). The complete condition list appears in the sidebar of this page; each condition links to a page listing every recruiting trial in that area, regardless of sponsor.

How do I join a Children's Hospital Medical Center, Cincinnati clinical trial?

Joining a clinical trial is a medical decision that should always involve your treating physician. Each trial page on this site includes the eligibility criteria translated into plain English alongside the official clinical text, plus the contact information that the sponsor has registered with ClinicalTrials.gov. Bring the trial information to your doctor before reaching out — they can review the full inclusion and exclusion criteria against your medical history and help you decide whether to pursue screening.

What does the trial phase mean?

Phase 1 trials test safety and dosing in small groups (often 20–80 healthy volunteers or patients). Phase 2 trials evaluate efficacy and side effects in larger groups (100–300 patients with the target condition). Phase 3 trials confirm efficacy and monitor safety in the largest groups (300–3,000+ patients) and form the basis of an FDA approval submission. Phase 4 studies happen after a treatment is approved, monitoring long-term safety and effectiveness in real-world use. Some trials register without a phase — common for device, behavioral, or observational studies.

Where does this trial data come from?

All trial data is pulled directly from the ClinicalTrials.gov API v2, the official federal trial registry maintained by the National Library of Medicine at NIH. Under FDAAA 801, most U.S. drug and device trials are required to register, making ClinicalTrials.gov the most comprehensive source. Sponsors are responsible for keeping their listings current; trial status can shift between data refreshes.

How This Sponsor Page Is Built

Every count on this page is derived directly from ClinicalTrials.gov API v2 records. Trial counts include all trials currently registered to this sponsor; the recruiting count reflects trials with status "Recruiting" or equivalent. Plain-English eligibility translations on each linked trial page preserve the original clinical text alongside an accessible version. Read the full methodology for the data pipeline and limitations.

Source: ClinicalTrials.gov API v2, maintained by the National Library of Medicine at NIH. Public domain. Cite as: "TrialFinderData. Data: ClinicalTrials.gov."

Medical disclaimer: This page is informational, not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Last updated 2026-06-26 · 25 trials tracked for Children's Hospital Medical Center, Cincinnati.